DiaMedica Therapeutics Inc (DMAC) — Capital Reinvestment Ratio

Latest as of September 2010: 0.03x

DiaMedica Therapeutics Inc (DMAC) has a Capital Reinvestment Ratio of 0.03x as of September 2010, meaning it reinvests 0% of its operating cash flow ($392.76K) in capital expenditures ($11.57K). See DMAC net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$392.76K

USD

Capital Expenditures

$11.57K

USD

Data as of

Sep 2010

Most recent filing

Annual Capital Reinvestment Ratio for DiaMedica Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for DiaMedica Therapeutics Inc from None to None. For live market cap and broader valuation context, see DiaMedica Therapeutics Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow